ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
Provides Funding to Support Ongoing Activities Including Inventory Ramp, Plant Expansion, Product Launch and Plasma Collection Center Development RAMSEY, N.J. […]
Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
Canntab enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop TORONTO, Feb. 12, 2019 […]
Document Security Systems, Inc. Releases Advanced Brand Protection Application for Supply Chain Investigators
The Mobile App for Authentiguard™ Provides Unique Set of Capabilities Built Specifically to Assist in Investigations ROCHESTER, N.Y., Feb. 12, […]
FTI Consulting Continues Global Investment in Business Transformation Practice
Practice Adds Five Experts in the U.S. in Recent Months, Appoints Leader in Asia WASHINGTON, Feb. 12, 2019 (GLOBE NEWSWIRE) […]
Spark Therapeutics to Host Conference Call on Tuesday, Feb. 19 at 8:30 a.m. ET to Discuss 2018 Results and Recent Business Highlights
PHILADELPHIA, Feb. 12, 2019 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to […]
Aemetis Receives USDA Conditional Commitment for $125 Million, 20-year Financing of Riverbank Biorefinery
California Plant Designed to Produce Advanced Biofuels with Below Zero Carbon Emissions CUPERTINO, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) — […]
Pacira Expands EXPAREL Manufacturing Capacity to Meet Growing Demand
First of two dedicated suites at new manufacturing site to double previous capacity PARSIPPANY, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) […]
Loop Industries Completes and Expands Supply Agreement With Danone for 100% Sustainable PET
MONTREAL, Feb. 12, 2019 (GLOBE NEWSWIRE) — Loop Industries, Inc. (Nasdaq: Loop) (“Loop” or the “Company”), a leading technology innovator […]
Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan in Patients with Decompensated NASH Cirrhosis
SAN DIEGO, Feb. 12, 2019 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the completion of enrollment in ENCORE-LF, […]
TSX News -
Parkinson’s Disease: ProMIS Neurosciences Identifies Several Antibody Drug Candidates Showing Best-in-Class Selectivity for Toxic Forms of Alpha-Synuclein Compared to other Therapeutic Antibodies in Development
Competitive Differentiation of ProMIS Antibodies is Key to Ongoing Partnering Discussions with Large Pharmaceutical Companies TORONTO and CAMBRIDGE, Mass., Feb. […]
